Progyny Q3 revenue $205.4M (+68% YoY); raises FY2022 revenue guidance to $775-785M

Progyny, Inc.

2022-Q3 EPS reported $0.27 revenue$205,371,000

Revenue $205.4M (+68% YoY); net income $13.2M ($0.13 EPS) vs $16.8M ($0.17) year ago.
Adjusted EBITDA $35.0M (+112% YoY); margin 17.0% vs 13.5%.
Record 105 new client commitments in selling season; near 100% retention; anticipates 370 clients and 5.4M covered lives by 2023.
Raises full-year 2022 revenue guidance to $775-785M (55-57% growth); Q4 revenue guided $202.4-212.4M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Progyny, Inc. reported the three-month period ended September 30, 2022 results: revenue $205,371, net income $13,211, EPS $0.13. Guidance raised.

Period: the three-month period ended September 30, 2022
Revenue: $205,371
Net income: $13,211
EPS: $0.13
Guidance: raised
Result: reported results

Exact text from the filing

said Mark Livingston, Progyny’s Chief Financial Officer. Third Quarter 2022 Highlights: (unaudited; in thousands, except per share amounts) 3Q 2022 3Q 2021 Revenue $205,371 $122,284 Gross Profit $45,995 $28,492 Gross Margin 22.4% 23.3% Net Income $13,211 $16,796 Net Income per Diluted Share 1 $0.13 $0.17 Adjusted EBITDA 2 $34,957 $16,479 Adjusted

View on SEC.gov

Browse all earnings releases →

Progyny, Inc. filing history →

Source: SEC EDGAR

accession 0001551306-22-000028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.